Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
27.48
-0.70 (-2.48%)
Mar 5, 2026, 4:00 PM EST - Market closed
Genmab Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Genmab stock have an average target of 40.93, with a low estimate of 34 and a high estimate of 48. The average target predicts an increase of 48.94% from the current stock price of 27.48.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Genmab stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Buy | 3 | 2 | 2 | 2 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 6 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $40 | Buy | Initiates | $40 | +45.56% | Mar 2, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $45 → $40 | Strong Buy | Maintains | $45 → $40 | +45.56% | Feb 23, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $39 → $40 | Strong Buy | Maintains | $39 → $40 | +45.56% | Feb 18, 2026 |
| Jefferies | Jefferies | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +51.02% | Feb 17, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $34 | Hold | Initiates | $34 | +23.73% | Feb 16, 2026 |
Financial Forecast
Revenue This Year
4.38B
from 3.72B
Increased by 17.80%
Revenue Next Year
5.03B
from 4.38B
Increased by 14.86%
EPS This Year
14.49
from 15.37
Decreased by -5.73%
EPS Next Year
18.87
from 14.49
Increased by 30.22%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.7B | 5.6B | |||
| Avg | 4.4B | 5.0B | |||
| Low | 3.6B | 4.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 26.5% | 28.0% | |||
| Avg | 17.8% | 14.9% | |||
| Low | -2.5% | -4.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 22.43 | 25.71 | |||
| Avg | 14.49 | 18.87 | |||
| Low | 10.32 | 9.79 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 45.9% | 77.4% | |||
| Avg | -5.7% | 30.2% | |||
| Low | -32.9% | -32.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.